Literature DB >> 20553432

National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France.

Annabelle Servant-Delmas1, Mélanie Mercier, Marie-Hélène El Ghouzzi, Annie Girault, Françoise Bouchardeau, Josiane Pillonel, Syria Laperche.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) diversity is characterized by eight genotypes correlated to eight hepatitis B surface antigen (HBsAg) subtypes, which differ in their geographical distribution. STUDY DESIGN AND METHODS: To establish virologic characteristics and the evolution of HBV diversity, we carried out a study over a 9-year period in HBV-infected French blood donors. HBsAg subtyping based on specific antibody method concerned 2901 donors, from whom 940 have been analyzed by an S-gene sequencing to determine genotypes and S-gene mutations.
RESULTS: HBsAg subtypes were distributed as follows: ayw2, 34.4%; adw2, 25.7%; ayw1, 10.2%; ayw4, 14.9%; adr, 7.8%; ayw3, 6.4%; and adw4, 0.7%. Ayw4 (Genotype E) proportion increased over time in correlation with an increased proportion of subjects originated from sub-Saharan Africa. The genotype observed with the highest proportion was D (43.0%), then A (26.2%), E (17.5%), B (6.5%), C (6.4%), and F (0.4%). Genotype B had the highest proportion of hepatitis B e antigen (39.2%) and the highest viral loads (VLs). Forty-three (5.5%) isolates presented one (n=35) or multiple (n=8) amino acid envelope substitutions. Donors infected with mutated isolates had lowest VLs. rtA181T/sW172 stop mutation associated with resistance to nucleos(t)ide analogs was detected in two donors suggesting a transmission of these isolates.
CONCLUSION: This extensive study shows that HBV genotype evolution is closely linked to the geographical origin of subjects and that the occurrence of viral envelope mutants is not an exceptional event in healthy HBV chronic carriers. Blood donors rarely recruited in HBV studies provide further relevant information on the characteristics of HBV diversity.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2010        PMID: 20553432     DOI: 10.1111/j.1537-2995.2010.02725.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

1.  Comparative Performance of Three Rapid HBsAg Assays for Detection of HBs Diagnostic Escape Mutants in Clinical Samples.

Authors:  Annabelle Servant-Delmas; Thoai Duong Ly; Clémence Hamon; Ali Kassim Houdah; Syria Laperche
Journal:  J Clin Microbiol       Date:  2015-09-16       Impact factor: 5.948

2.  A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.

Authors:  Laure Boizeau; Annabelle Servant-Delmas; Alexandra Ducancelle; Stéphane Chevaliez; Vincent Thibault; Syria Laperche; Pierre Cappy
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma?

Authors:  Laure Boizeau; Syria Laperche; Nathalie Désiré; Catherine Jourdain; Vincent Thibault; Annabelle Servant-Delmas
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

4.  Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.

Authors:  Diderot Fopa; Daniel Candotti; Claude T Tagny; Camille Doux; Dora Mbanya; Edward L Murphy; Hany I Kenawy; Farha El Chenawi; Syria Laperche
Journal:  Blood Transfus       Date:  2019-11       Impact factor: 3.443

5.  Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay.

Authors:  Mélanie Mercier; Syria Laperche; Annie Girault; Camille Sureau; Annabelle Servant-Delmas
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

Review 6.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

7.  Hepatitis B Virus Genotype D Isolates Circulating in Chapecó, Southern Brazil, Originate from Italy.

Authors:  Carolina Souza Gusatti; Cintia Costi; Maria Laura Halon; Tarciana Grandi; Arlete Ferrari Rech Medeiros; Cláudia Maria Dornelles Silva; Selma Andrade Gomes; Marcia Susana Nunes Silva; Christian Niel; Maria Lucia Rosa Rossetti
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.

Authors:  Mikael Gencay; Kirsten Hübner; Peter Gohl; Anja Seffner; Michael Weizenegger; Dionysios Neofytos; Richard Batrla; Andreas Woeste; Hyon-Suk Kim; Gaston Westergaard; Christine Reinsch; Eva Brill; Pham Thi Thu Thuy; Bui Huu Hoang; Mark Sonderup; C Wendy Spearman; Stephan Pabinger; Jérémie Gautier; Giuseppina Brancaccio; Massimo Fasano; Teresa Santantonio; Giovanni B Gaeta; Markus Nauck; Wolfgang E Kaminski
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.

Authors:  Virginie Sauvage; Laure Boizeau; Daniel Candotti; Mathias Vandenbogaert; Annabelle Servant-Delmas; Valérie Caro; Syria Laperche
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

10.  Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system.

Authors:  Vincent Thibault; Syria Laperche; Valérie Thiers; Sophie Sayon; Marie-José Letort; Elisabeth Delarocque-Astagneau; Denise Antona
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.